The report is based on 2014-23 drug shortage data from the FDA’s Center for Drug Evaluation and Research.
As of November 2020, the average duration of a drug shortage was 733 days, or about two years. This duration increased to 1,202 days — or 3.3 years — as of December 2023, according to the report.
“Increased durations of drug shortages should be concerning as they impact patient care, prolonging or hindering access to drugs,” USP said in the report. “Persistence in drug shortages are due to the compounding economic forces, as discussed in many studies, and the market’s inability to resolve with traditional market economy responses.”
USP also noted the report may not account for all drug shortages as the FDA’s database primarily lists medically necessary products.
View the full report here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
